Bojungbangdocktang inhibits vascular endothelial growth factor induced angiogenesis via blocking the VEGF/VEGFR2 signaling pathway in human umbilical vein endothelial cells

作     者：JANG Yu-Sung LEE Eun-Ok LEE Hyo-Jung LEE Hyo-Jeong KIM Kwan-Hyun WON Sook-Hyun LEE Jae-Dong AHN Kwang Seok AHN Kyoo Seok KIM Jung-Hyo YU Young-Beob KIM Sung-Hoon 

作者机构：College of Oriental Medicine Kyunghee University 1 Hoegidong Dongdaemungu Seou1130-701 Republic of Korea Chosun Nursing College 375 Seosuk-dong Dong-gu Gwangju 501-759 Korea Department of Herbal Pharmaceutical Korea Institute of Oriental Medicine Jeonmin dong Youseonggu Daejeon 305-811 Republic of Korea 

出 版 物：《Chinese Science Bulletin》 (CHINESE SCIENCE BULLETIN)

年 卷 期：2009年第54卷第2期

页      面：227-233页

核心收录：

学科分类：1001[医学-基础医学(可授医学、理学学位)] 100101[医学-人体解剖与组织胚胎学] 10[医学] 

基　　金：Supported by the Korea Science and Engineering Foundation Grant from the Korean Government (Ministry of Science and Technology) (Grant No. R13-2007-019-00000-0) 

主　　题：血管新技术 人大动脉内皮细胞 HUVECs VEGFR2 

摘      要：Oriental herbal medicines have been widely used for the prevention or treatment of various diseases including cancer in Asia. However, to prove their chemo preventive efficacies in modern times, scientific evidence for those herbal medicines is required. Thus, in the present study, an effective herbal cocktail Bojungbangdocktang (BJBDT) was investigated to elucidate antiangiogenic mechanism in vitro and in vivo. BJBDT significantly inhibited vascular endothelial growth factor (VEGF) induced proliferation in HUVECs at nontoxic concentrations, despite weak cytotoxicity against human umbilical vein endothelial cells (HUVECs). BJBDT also significantly suppressed VEGF-induced migration and tube formation of HUVECs. Furthermore, BJBDT treatment resulted in pale color and low hemoglobin level in Matrigel plugs, as well as dark red color and high hemoglobin level in untreated control. Interestingly, BJBDT specifically inhibited the binding of VEGF to vascular endothelial growth factor receptor 2 (VEGFR2), but not VEGFR1. In addition, friedelin, formononetin, ginsenoside Rb1, naringin, atractyloside, diosgenin, and allantonin were identified from BJBDT by high-performance liquid chromatography (HPLC) analysis as a quality of control. Taken together, these results suggest that BJBDT is a potent angiogenesis inhibitor blocking the VEGF/VEGFR2 signaling pathway in HUVECs.